Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-01-09
1998-10-06
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 424 851, A61K 3800
Patent
active
058176250
ABSTRACT:
The present invention provides methods of preventing oral mucositis in a subject susceptible to mucositis which comprises administering to the subject a prophylactically effective amount of Transforming Growth Factor Beta. Typically, administration is topical and initiated prior to anti-neoplastic therapy such as radiation treatment or chemotherapy. The invention is particularly suited for pediatric patients.
REFERENCES:
patent: 4863902 (1989-09-01), Amagase
patent: 4929442 (1990-05-01), Powell
patent: 5102870 (1992-04-01), Florine et al.
patent: 5104977 (1992-04-01), Sporn
patent: 5108989 (1992-04-01), Amento et al.
patent: 5147854 (1992-09-01), Newman
Brown et al. "Enhancement of Epidermal Regeneration by Biosynthetic Epidermal Growth Factor," Journal of Experimental Medicine, vol.163, pp. 1319-1324, (1986).
Epstein, "The Painful Mouth," Infectious Syndromes of the Head and Neck, vol. 2, pp. 184-202, (1988).
Gabrilove et al., "Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium," New England Journal of Medicine, vol. 318, pp. 1414-1422 (1988).
Konturek et al., "Gastric Cytoprotection by Epidermal Growth Factor," Gastroenterology, vol. 81, pp. 438-443. (1981).
Lawrence et al., "Reversal of an Adriamycin Induced Healing Impairment with Chemoattractants and Growth Factors," Ann. Surg., vol.203, pp. 142-147, (1984).
Niall et al., "The Effect of Epidermal Growth Factor on Wound Healing in Mice," Journal of Surgical Research, vol. 33, pp. 164-169. (1982).
Peterson et al., "Oral Complications of Cancer Chemotherapy: Present Status and Future Studies," Cancer Treatment Reports, vol. 66, pp. 1251-1256. (1982).
Robinson et al., "Epidermal Growth Factor (bEGF) Has No Effect on Murine Intestine Epithelial Damage and Regeneration After Melphalan," Br. J. Cancer, vol.52, pp. 733-737, (1985).
Sonis et al., "An Animal Model for Mucositis Induced by Cancer Chemotherapy," Oral Surg. Oral Med. Oral Pathol., vol. 69, pp. 437-443, (1990).
Sonis et al., "Effect of Epidermal Growth Factor on Ulcerative Mucositis in Hamsters That Receive Cancer Chemotherapy," Oral Surg. Oral Med. Oral Pathol. vol.74, pp. 749-755, (1992).
Southgate et al., "Primary Culture of Human Oral Epithelial Cells," Laboratory Investigation, vol. 56, 211-223. (1987).
Steidler et al., "Histomorphological Effects of Epidermal Growth Factor on Skin and Oral Mucsa in Neonatal Mice," Archives or Oral Biology, vol. 25, pp. 37-43, (1980).
Webster's II New Riverside University Dictionary p. 833.
Huff Sheela J.
Oncogene Science, Inc.
Scheiner Toni R.
White John P.
LandOfFree
Methods of prevention of oral mucositis with transforming growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of prevention of oral mucositis with transforming growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of prevention of oral mucositis with transforming growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-77029